⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2017World Journal of GastroenterologyOpen Access

Expression of Interleukin-26 is upregulated in inflammatory bowel disease

View Full Paper

Ask AI

Bookmark

Share

Abstract

These results suggest that IL-26 plays a role in the pathophysiology of IBD through induction of inflammatory mediators.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Fujii et al. (2017) studied this question.

synapsesocial.com/papers/69df07503b0ba53fb37a0e50 https://doi.org/10.3748/wjg.v23.i30.5519

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cellsOriginal Research · 2012 · 32 citations
2IL-6 Secretion by Human Pancreatic Periacinar Myofibroblasts in Response to Inflammatory MediatorsOriginal Research · 2002 · 142 citations
3IL-26 Is Overexpressed in Rheumatoid Arthritis and Induces Proinflammatory Cytokine Production and Th17 Cell GenerationOriginal Research · 2012 · 165 citations
4Expression of IL-24, an Activator of the JAK1/STAT3/SOCS3 Cascade, Is Enhanced in Inflammatory Bowel DiseaseOriginal Research · 2009 · 154 citations
5IL-17 Selectively Down-Regulates TNF-α-Induced RANTES Gene Expression in Human Colonic Subepithelial MyofibroblastsOriginal Research · 2002 · 64 citations